Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Updates in Celiac Disease: Moving Forward Despite Setbacks
-
- Industry Insights into Celiac Disease
- 7 Recent Developments in Dietary Therapies for IBS
- Determining Best Management for Serrated Adenomas Francis A. Farraye, MD, MSc; Christopher S. Huang, MD; Michael J. O'Brien, MD, MPH
- FDA Advisory Committee Recommends Bezlotoxumab for Recurring C. difficile Infection
- FDA Approves Ocaliva for Primary Biliary Cholangitis
- FDA Delays Approval Decision for Merck’s Bezlotoxumab
- Hope on the Horizon for Celiac Disease
- The Patient with Hepatic Encephalopathy
-
- CDC: US has Sufficient Health Care Resources to Achieve CRC Screening Goals
- Global Rates of Post-colonoscopy Complications Remain Low
- Less Than 3% of IBD Patients Develop Colorectal Cancer After Colectomy
- Probiotic Yeast Improves Abdominal Pain, Bloating in IBS-C Patients
- Relamorelin Improves Diabetic Gastroparesis Symptoms
- Task Force Recommends Routine Colorectal Cancer Screening for Adults Aged 50 to 75 Years
- Fructose Malabsorption, Symptom Severity, IBS Subtype Predict Response to Low FODMAP Diet
- Nivolumab Demonstrates Encouraging Activity in Metastatic Colorectal Cancer
-
- AGA, Takeda Announce Three New Grants to Support Young IBD Researchers
- Mass General, Seres Partner in Microbiome Research
- Mayo Clinic First to Offer New Device for Fecal Incontinence
- Shire to License Investigational Biologic for IBD from Pfizer